Patient involvement in selection of immunosuppressive regimen following transplantation

Joyce Popoola,1,3 Helen Greene,2 Margaret Kyegombe,2 Iain A MacPhee1,3 1Department of Nephrology and Transplantation, 2Department of Pharmacy, St George’s Healthcare NHS Trust, 3St George’s University of London, London, UK Abstract: Transplantation has made a consider...

Full description

Bibliographic Details
Main Authors: Popoola J, Greene H, Kyegombe M, MacPhee IA
Format: Article
Language:English
Published: Dove Medical Press 2014-12-01
Series:Patient Preference and Adherence
Online Access:http://www.dovepress.com/patient-involvement-in-selection-of-immunosuppressive-regimen-followin-peer-reviewed-article-PPA
id doaj-9df82db7d0764ccab879e77e3e3fcec7
record_format Article
spelling doaj-9df82db7d0764ccab879e77e3e3fcec72020-11-25T00:05:04ZengDove Medical PressPatient Preference and Adherence1177-889X2014-12-012014default1705171219530Patient involvement in selection of immunosuppressive regimen following transplantationPopoola JGreene HKyegombe MMacPhee IA Joyce Popoola,1,3 Helen Greene,2 Margaret Kyegombe,2 Iain A MacPhee1,3 1Department of Nephrology and Transplantation, 2Department of Pharmacy, St George’s Healthcare NHS Trust, 3St George’s University of London, London, UK Abstract: Transplantation has made a considerable difference to the lives of many patients. However, feedback from patients indicates that although having a transplant is a hugely positive experience, having to take medications indefinitely is one of the biggest challenges. An ideal scenario would be no medications following a transplant. A compromise would be a minimal number of medications, with minimal restrictions and as simple a regimen as possible. Although there is considerable research going into fine-tuning the management of the immune response to a transplant, to date there is no universal regimen that enables patients to remain free of immunosuppressant medications, making adherence paramount to maintain long-term allograft survival. This paper reviews the available immunosuppressant regimens and factors influencing choice from both the clinician’s and the patient’s perspective. Factors influencing the decision-making process, such as quality of life for patients, their satisfaction, acceptability, and adherence uptake are reviewed. We conclude with a further assessment of patient choice as a factor in regimen selection, its impact on adherence, and its implications. Keywords: adherence, transplant, allograft, immunosuppressants, patient involvement, satisfaction, decision-makinghttp://www.dovepress.com/patient-involvement-in-selection-of-immunosuppressive-regimen-followin-peer-reviewed-article-PPA
collection DOAJ
language English
format Article
sources DOAJ
author Popoola J
Greene H
Kyegombe M
MacPhee IA
spellingShingle Popoola J
Greene H
Kyegombe M
MacPhee IA
Patient involvement in selection of immunosuppressive regimen following transplantation
Patient Preference and Adherence
author_facet Popoola J
Greene H
Kyegombe M
MacPhee IA
author_sort Popoola J
title Patient involvement in selection of immunosuppressive regimen following transplantation
title_short Patient involvement in selection of immunosuppressive regimen following transplantation
title_full Patient involvement in selection of immunosuppressive regimen following transplantation
title_fullStr Patient involvement in selection of immunosuppressive regimen following transplantation
title_full_unstemmed Patient involvement in selection of immunosuppressive regimen following transplantation
title_sort patient involvement in selection of immunosuppressive regimen following transplantation
publisher Dove Medical Press
series Patient Preference and Adherence
issn 1177-889X
publishDate 2014-12-01
description Joyce Popoola,1,3 Helen Greene,2 Margaret Kyegombe,2 Iain A MacPhee1,3 1Department of Nephrology and Transplantation, 2Department of Pharmacy, St George’s Healthcare NHS Trust, 3St George’s University of London, London, UK Abstract: Transplantation has made a considerable difference to the lives of many patients. However, feedback from patients indicates that although having a transplant is a hugely positive experience, having to take medications indefinitely is one of the biggest challenges. An ideal scenario would be no medications following a transplant. A compromise would be a minimal number of medications, with minimal restrictions and as simple a regimen as possible. Although there is considerable research going into fine-tuning the management of the immune response to a transplant, to date there is no universal regimen that enables patients to remain free of immunosuppressant medications, making adherence paramount to maintain long-term allograft survival. This paper reviews the available immunosuppressant regimens and factors influencing choice from both the clinician’s and the patient’s perspective. Factors influencing the decision-making process, such as quality of life for patients, their satisfaction, acceptability, and adherence uptake are reviewed. We conclude with a further assessment of patient choice as a factor in regimen selection, its impact on adherence, and its implications. Keywords: adherence, transplant, allograft, immunosuppressants, patient involvement, satisfaction, decision-making
url http://www.dovepress.com/patient-involvement-in-selection-of-immunosuppressive-regimen-followin-peer-reviewed-article-PPA
work_keys_str_mv AT popoolaj patientinvolvementinselectionofimmunosuppressiveregimenfollowingtransplantation
AT greeneh patientinvolvementinselectionofimmunosuppressiveregimenfollowingtransplantation
AT kyegombem patientinvolvementinselectionofimmunosuppressiveregimenfollowingtransplantation
AT macpheeia patientinvolvementinselectionofimmunosuppressiveregimenfollowingtransplantation
_version_ 1725426416680435712